DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 90 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,459,495 | -7.4% | 1,136,607 | +2.5% | 0.00% | 0.0% |
| Q2 2023 | $15,620,426 | -5.2% | 1,109,405 | +4.1% | 0.00% | 0.0% |
| Q1 2023 | $16,471,312 | +110171.9% | 1,066,104 | +17.0% | 0.00% | 0.0% |
| Q4 2022 | $14,937 | -99.9% | 911,394 | +3.8% | 0.00% | 0.0% |
| Q3 2022 | $16,237,000 | +49.6% | 877,693 | +6.3% | 0.00% | 0.0% |
| Q2 2022 | $10,856,000 | +82.6% | 825,606 | +28.7% | 0.00% | +100.0% |
| Q1 2022 | $5,944,000 | -22.3% | 641,264 | -18.1% | 0.00% | 0.0% |
| Q4 2021 | $7,654,000 | -69.5% | 783,455 | +6.1% | 0.00% | -66.7% |
| Q3 2021 | $25,102,000 | -7.4% | 738,758 | -0.2% | 0.00% | -25.0% |
| Q2 2021 | $27,103,000 | -14.1% | 740,330 | +5.2% | 0.00% | -20.0% |
| Q1 2021 | $31,570,000 | -15.3% | 704,063 | +7.8% | 0.01% | -16.7% |
| Q4 2020 | $37,257,000 | +17.7% | 652,839 | +5.8% | 0.01% | 0.0% |
| Q3 2020 | $31,666,000 | +17.6% | 617,287 | +36.9% | 0.01% | 0.0% |
| Q2 2020 | $26,919,000 | +94.7% | 450,768 | +34.2% | 0.01% | +50.0% |
| Q1 2020 | $13,823,000 | -62.6% | 335,778 | -43.4% | 0.00% | 0.0% |
| Q4 2019 | $36,948,000 | +283.4% | 593,640 | +109.1% | 0.00% | +100.0% |
| Q3 2019 | $9,637,000 | +97.2% | 283,962 | +31.0% | 0.00% | +100.0% |
| Q2 2019 | $4,888,000 | +15.9% | 216,807 | +19.3% | 0.00% | 0.0% |
| Q1 2019 | $4,218,000 | -39.8% | 181,746 | -45.6% | 0.00% | 0.0% |
| Q4 2018 | $7,006,000 | +29.5% | 333,808 | +138.9% | 0.00% | -50.0% |
| Q3 2018 | $5,411,000 | +4.3% | 139,747 | +6.0% | 0.00% | 0.0% |
| Q2 2018 | $5,186,000 | +126.4% | 131,794 | +15.3% | 0.00% | +100.0% |
| Q1 2018 | $2,291,000 | -16.2% | 114,332 | -5.2% | 0.00% | 0.0% |
| Q4 2017 | $2,735,000 | – | 120,651 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $72,236,000 | 20.73% |
| SV Health Investors, LLC | 449,951 | $26,871,000 | 18.64% |
| Redmile Group, LLC | 4,978,941 | $297,342,000 | 5.49% |
| Sunesis Advisors, LLC | 96,299 | $5,751,000 | 5.29% |
| Eversept Partners, LP | 418,652 | $25,001,897 | 3.43% |
| Opaleye Management Inc. | 222,000 | $13,081,000 | 2.64% |
| Avoro Capital Advisors LLC | 1,860,000 | $111,079,000 | 2.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 282,965 | $16,899,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 224,359 | $13,399,000 | 1.23% |
| Artal Group S.A. | 650,000 | $38,818,000 | 1.09% |